India · Delayed Price · Currency is INR Narayana Hrudayalaya Earnings Call Transcripts
Fiscal Year 2026
-
India delivered strong profit and margin expansion, led by transformation and high-end procedures, while UK and Cayman segments focus on operational improvements and market share gains. CapEx and expansion are funded by internal accruals and debt, with no equity raise planned.
-
Q2 FY2026 delivered strong revenue and EBITDA growth, led by Cayman and India operations, with robust hospital margins and improving insurance performance. India saw 20% EBITDA growth, while the Cayman business posted 70% revenue growth year-over-year.
-
Q1 FY 2026 featured stable hospital margins, strong ARPP growth, and expansion in Cayman and India. Integrated Care and insurance businesses are scaling but currently dilute consolidated margins, with break-even expected in coming quarters. Oncology and digital initiatives continue to drive growth.
Fiscal Year 2025
-
The acquisition of a U.K. hospital group division is funded offshore, debt-free, and aims to replicate operational efficiencies from previous international ventures. The deal targets margin expansion, increased private payer mix, and scalable growth in a stable, regulated market.
-
Cayman operations delivered strong revenue and margins, while India business sustained growth through throughput and premium services. CapEx is focused on expansion, with prudent debt use and continued investment in insurance and clinics. Working capital was impacted by delayed government payments.
-
Q3 FY25 delivered strong margin recovery and revenue growth in both India and Cayman, driven by operational efficiency and new service launches. Strategic investments, including a Bahamas stake and insurance product rollouts, support future growth, with CapEx funded mainly by long-term debt.
-
Strong revenue growth in India was driven by higher ARPP and a shift to domestic patients, while the new Cayman facility is set for full launch soon with margin dilution expected for four-to-five quarters. CapEx plans target 1,500 new beds, and integrated care and insurance businesses are scaling with controlled cash burn.
-
Record quarterly revenue and improved margins were achieved despite seasonal headwinds, with strong performance in both India and overseas segments. Major CAPEX is underway for new hospitals in Kolkata and Bangalore, funded primarily through debt, while digital and clinical innovations continue to drive operational efficiency.